🌟 The Evolution Research Group team is excited to attend the Alzheimer’s Association International Conference! 🌟 Join the ERG Team for the 2024 Alzheimer’s Association International Conference (AAIC) to be held in Philadelphia, PA! The event will take place July 28-Aug 1. Looking forward to connecting with researchers, healthcare professionals, and advocates from around the world to advance our understanding of Alzheimer’s and dementia. Let's make strides towards better care, prevention, and treatment for this challenging disease. Our industry-leading experts will be there in full force and look forward to collaborating with you! Contact us TODAY to set up a time to get together! accountdirectors@ergclinical.com or go to ERG | Contact Us (ergclinical.com) Stay tuned for updates and insights! 🧠💜 #AAIC #EndAlz #ResearchMatters #AlzheimersAwareness #EvolutionResearchGroup
Evolution Research Group
Research Services
New Providence, New Jersey 2,874 followers
Quality Clinical Research Today for a Healthier Tomorrow
About us
ERG is a leading U.S. based, privately held, independent clinical research site company, and provider of clinical development services with an expertise in early and late stage neuroscience drug development. With 21 wholly owned clinical sites and 5 affiliated sites, we conduct in-patient and out-patient phase I-IV clinical research studies. ERG has 340+ in-patient beds, a large and growing database of patients suffering from mental illness, neurological disorders, sleep disorders, addictions, Acute and Chronic Pain, diabetes and other illnesses as well as normal healthy volunteers who participate in trials for the advancement of medicine. With access to over 32 million patients/subjects and 5000 + completed trials, ERG continues to grow its capabilities and expand into indications where there are tremendous unmet medical needs in the United States and globally. The ERG portfolio of sites we own consists of Woodland International Research Group, Woodland Research Northwest, Midwest Clinical Research, Pacific Research Network, Clinical Pharmacology of Miami, Brain Matters Research, Neuropsychiatric Research Center, Richmond Behavioral Associates, Finger Lakes Clinical Research, Endeavor Clinical Trials, and HD Research, all supported by an industry leading centralized infrastructure located in New Jersey. ERG offers consulting services to pharmaceutical and CRO clients, including access to key opinion leaders in Schizophrenia, Pain, Alzheimer’s disease, Sleep Disorders, Depression, Hepatic/Renal Impairment, Podiatry and Clinical Pharmacology. This includes Rater Training Services, Centralized Data Services (ECG, PSG, EEG, qEEG, Actigraphy), Medical Writing Services, Study Feasibility and Site Recommendation ERG also offers general consulting in study design, protocol review and budget planning, vendor resources, Scientific Advisory Board Planning and Implementation, study feasibility and site recommendations.
- Website
-
http://ergclinical.com
External link for Evolution Research Group
- Industry
- Research Services
- Company size
- 501-1,000 employees
- Headquarters
- New Providence, New Jersey
- Type
- Privately Held
- Founded
- 2014
- Specialties
- Psychiatry: Schizophrenia (adult and adolescent), Bipolar Disorder (adult and pediatric/adolescent), Addiction (alcohol, cocaine), Opioid Use Disorder, Depressive Disorders (adult and pediatric/adolescent), ADHD (adult and pediatric/adolescent), Anxiety Disorders, Eating Disorders, PTSD, OCD, Neurology: Alzheimer’s Disease, Multiple Sclerosis, Parkinson’s Disease, Essential Tremor,Sleep Disorders (insomnia, narcolepsy, RLS, apnea), Tourette’s Syndrome (adult and adolescent), Huntington’s Disease, Tardive Dyskinesia, Epilepsy, Pain: Post-Op Pain (breast augmentation, abdominoplasty, bunionectomy, total knee replacement, other orthopedic), PHN, Fibromyalgia, OA, DPN, Gout, CRPS, Headache (Migraine/Tension), Healthy Volunteers: First-in-Human, First-to-File, PK/PD, SAD/MAD, DDI, FE, BA/BE, QTc/TQT, Renal Impairment and Hepatic Impairment, Geriatric and Healthy Geriatric, Smoking, Vaccine, Endocrinology: Type 1-2 Diabetes, Obesity, Liver Disease: Hepatitis B and C, NASH, Podiatry, Respiratory: Asthma (adult and pediatric/adolescent), COPD Cardiovascular Disorders: Hypertension, Hypercholesterolemia, Sexual Dysfunction Disorders, Asian Bridging, Respiratory: Asthma (adult and pediatric/adolescent), COPD Cardiovascular Disorders: Hypertension, Hypercholesterolemia, and Gastrointestinal: GERD (adult and pediatric)
Locations
Employees at Evolution Research Group
Updates
-
We are thrilled to hear that the FDA has granted approval for Kisunla, more commonly known as donanemab, for Alzheimer’s disease. This approval marks a significant milestone in our ongoing commitment to advancing treatments for neurodegenerative conditions. The approval by the FDA underscores the dedication and hard work of Investigators, researchers, and partners who have been relentless in their pursuit of a world without Alzheimers’ disease. We extend our gratitude to all the patients, caregivers, and clinical investigators who participated in the clinical trials, as their contributions have been invaluable to this achievement. This approval is a testament to the collaborative efforts within the scientific community to address one of the most challenging diseases of our time. Evolution Research Group remains steadfast in our mission to improve patient outcomes and enhance the quality of life for those affected by Alzheimer’s. We are committed to continuing our research and development efforts to bring forward new and effective treatments. Thank you again to our sites, teams, and volunteers!
-
-
Our team is arriving and gearing up for an exciting time at #ADA2024! 🌞 We’re all about collaboration and innovation- it’s not too late to schedule some time to meet with our wonderful team members, Erica & Clay. Let’s chat, share ideas, and work together to advance the future of endocrinology and metabolic research.
-
-
Synergy Research Center joins the Evolution Research Group family! We are thrilled to announce that Synergy Research Center has joined the Evolution Research Group family as our newest portfolio company! Located in Lemon Grove, San Diego, Synergy Research Center has been a distinguished research facility for over two decades, specializing in phase I through phase III clinical research studies. Synergy has comprehensive inpatient and outpatient capabilities, focusing primarily on psychiatric therapeutic areas including schizophrenia, bipolar disorder, and depression. Their expertise extends beyond psychiatry, encompassing successful trials in migraine, healthy normal volunteers, diabetes, Alzheimer’s disorder, as well as many other CNS disorders. We are excited to have co-Founder of Synergy Research Center, Woody Woodaman, join our BD team and his son Ryan Woodaman, who currently runs operations at Synergy Research Center, taking over operational leadership of the region, working closely with our PRN team.
-
-
Today we celebrate Juneteenth, a pivotal moment in American history symbolizing freedom and resilience. At Evolution Research Group, our teams and sites are committed to fostering diversity and equity in clinical research as well as our workforce. Together, we strive for a future where everyone’s voice is heard, valued, and represented.
-
-
We are looking for an experienced LPN with Psych experience in Staten Island. $3k SOB, apply today! https://lnkd.in/eYQdmPbi
LPN/RN-FT Days ($3000 SOB)
paycomonline.net
-
IN CASE YOU MISSED IT: A panel of federal health advisers has recommended the FDA approve a new medication, donanemab, developed by Eli Lilly in the fight against Alzheimer's. This drug has shown promise in slowing the progression of Alzheimer's disease, potentially delaying cognitive decline by several months. We at Evolution Research Group extend our deepest gratitude to our sites and teams that conducted these trials and to the volunteers who participated to make moments like this possible. Your courage and dedication are the driving force behind these advancements. Together, we are making progress toward a brighter future for those affected by Alzheimer's. Thank you for your support and commitment to advancing medical science. Accolades all around to our colleagues at Eli Lilly for all their hard work in the fight against Alzheimer's.
-
Evolution Research Group reposted this
Evolution Research Group, LLC is proud to announce our Co-Founder and Chief Executive Officer, Lori Wright, was recognized as a Master Dealmaker at the New York Dealmakers Conference, sponsored by Bank of America | Merrill. The event featured an all-star lineup of local entrepreneurs, investors and advisers discussing how high interest rates, political uncertainty and the rise of AI are changing the M&A Landscape. The day closed with the Dealmakers of the Year Awards and Dealmakers Hall of Fame Induction where Lori was among a prestigious class of honorees. Lori was truly honored to be amongst many other impressive entrepreneurs in the 2024 Hall of Fame class.
-
-
Evolution Research Group, LLC is proud to announce our Co-Founder and Chief Executive Officer, Lori Wright, was recognized as a Master Dealmaker at the New York Dealmakers Conference, sponsored by Bank of America | Merrill. The event featured an all-star lineup of local entrepreneurs, investors and advisers discussing how high interest rates, political uncertainty and the rise of AI are changing the M&A Landscape. The day closed with the Dealmakers of the Year Awards and Dealmakers Hall of Fame Induction where Lori was among a prestigious class of honorees. Lori was truly honored to be amongst many other impressive entrepreneurs in the 2024 Hall of Fame class.
-